{"SPADE_UN_21684": {"Sequence Information": {"Peptide Name": "Tritrpticin [W6,7A]", "Sequence": "VRRFPAAWPFLRR", "Sequence Length": 13, "Biological Activity": ["Anti-Gram-", "Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "P51524", "uniprotUrl": "http://www.uniprot.org/uniprot/P51524", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}, {"uniprotId": "P51525", "uniprotUrl": "http://www.uniprot.org/uniprot/P51525", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."}], "Literature": [{"Title": "Position-Dependent Influence of the Three Trp Residues on the Membrane Activity of the Antimicrobial Peptide, Tritrpticin.", "Pubmed ID": "27025758", "Reference": "Antibiotics (Basel). 2014;3:595-616", "Author": "Arias M, Nguyen LT, Kuczynski AM, Lejon T, Vogel HJ", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/27025758"}, {"Title": "Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin.", "Pubmed ID": "32126228", "Reference": "Biochim Biophys Acta. 2020;1862:183228", "Author": "Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/32126228"}], "Mass": 1671.99, "PI": 12.0, "Net Charge": 4, "Hydrophobicity": -0.38, "Frequent Amino Acids": "RAF", "Absent Amino Acids": "CDEGHIKMNOQSTUY", "Basic Residues": 4, "Acidic Residues": 0, "Hydrophobic Residues": 6, "Polar Residues": 7, "Positive Residues": 4, "Negative Residues": 0, "SPADE ID": "SPADE_UN_21684", "Similar Sequences": [{"SPADE_ID": "SPADE_N_06501", "Similarity": 1.0, "Sequence": "VRRFPPFLRR"}, {"SPADE_ID": "SPADE_N_09256", "Similarity": 1.0, "Sequence": "GVRCVRRGVRCVRR"}, {"SPADE_ID": "SPADE_N_09258", "Similarity": 1.0, "Sequence": "GVRVRRGVRVRR"}], "Hemolytic Activity": "Human PBMC:IC50=>=65 µM,Human erythrocytes:50% Hemolysis=>=65 µM", "Target Organism": "Escherichia coli ATCC 25922(MIC=64-128µM),Escherichia coli ATCC 25922(MBC=64-128µM),Jurkat T-cell leukemia(IC50=>=65µM)"}}}